BOSTON (AP) — BOSTON (AP) — Zevra Therapeutics, Inc. (ZVRA) on Wednesday reported first-quarter net income of $37.9 million.
On a per-share basis, the Boston-based company said it had profit of 60 cents. Earnings, adjusted for non-recurring gains, came to 18 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 6 cents per share.
The specialty pharmaceutical company posted revenue of $36.2 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $31.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZVRA at https://www.zacks.com/ap/ZVRA
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
